
Effect of SGLT2 Inhibitors on Diabetes Progression in Statin-Treated Patients: A Population-Based Cohort Study
Introduction Diabetes mellitus (DM) and hypercholesterolemia are important risk factors for atherosclerotic cardiovascular diseases. Statins are recommended as the first-line therapy for controlling low-density lipoprotein cholesterol.1,2 However, studies …